ATE149310T1 - Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz - Google Patents

Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz

Info

Publication number
ATE149310T1
ATE149310T1 AT92921102T AT92921102T ATE149310T1 AT E149310 T1 ATE149310 T1 AT E149310T1 AT 92921102 T AT92921102 T AT 92921102T AT 92921102 T AT92921102 T AT 92921102T AT E149310 T1 ATE149310 T1 AT E149310T1
Authority
AT
Austria
Prior art keywords
formulation
eye
fluorescently labelled
thin film
cornea
Prior art date
Application number
AT92921102T
Other languages
English (en)
Inventor
Abhay Joshi
David Meadows
Jerry Paugh
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE149310T1 publication Critical patent/ATE149310T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/13—Ophthalmic microscopes
    • A61B3/135—Slit-lamp microscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
    • A61B3/1241—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes specially adapted for observation of ocular blood flow, e.g. by fluorescein angiography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT92921102T 1991-09-13 1992-09-08 Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz ATE149310T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/759,530 US5323775A (en) 1991-09-13 1991-09-13 Diagnostic method for determining precorneal retention time of ophthalmic formulations

Publications (1)

Publication Number Publication Date
ATE149310T1 true ATE149310T1 (de) 1997-03-15

Family

ID=25056002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921102T ATE149310T1 (de) 1991-09-13 1992-09-08 Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz

Country Status (7)

Country Link
US (2) US5323775A (de)
EP (1) EP0603338B1 (de)
AT (1) ATE149310T1 (de)
AU (1) AU2670892A (de)
DE (1) DE69217969T2 (de)
ES (1) ES2100362T3 (de)
WO (1) WO1993005699A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101290B (pt) * 1993-06-18 2000-10-31 Fernandes Jose Guilherme Da Cu Fluorometro para medicao da concentracao de fluoroforos de localizacao ocular
US5553617A (en) * 1995-01-20 1996-09-10 Hughes Aircraft Company Noninvasive method and apparatus for determining body chemistry
US6736778B2 (en) 1997-12-22 2004-05-18 Francis Y. Falck, Jr. Replaceable prism for applanation tonometer
US6179779B1 (en) 1997-12-22 2001-01-30 Ffhk Development Company Llc Replaceable prism system for applanation tonometer
CA2398029A1 (en) 2000-02-08 2001-08-16 Cornell Research Foundation, Inc. Multiphoton excitation through optical fibers for fluorescence spectroscopy
DE60128138T2 (de) * 2000-11-02 2008-01-03 Cornell Research Foundation, Inc. In vivo multiphoton diagnostische detektion und bilddarstellung einer neurodegenerativen erkrankung
CA2535843A1 (en) * 2003-08-19 2005-06-23 Cornell Research Foundation, Inc. Optical fiber delivery and collection system for biological applications such as multiphoton microscopy, spectroscopy, and endoscopy
US8316477B2 (en) * 2005-10-24 2012-11-27 Sperian Eye & Face Protection, Inc. Cartridge assembly for a self-contained emergency eyewash station
WO2007050525A1 (en) * 2005-10-24 2007-05-03 Sperian Eye & Face Protection, Inc. Emergency eyewash station having an expandable bellows waste collection system
WO2007050524A1 (en) * 2005-10-24 2007-05-03 Sperian Eye & Face Protection, Inc. Pump assembly for an emergency eyewash station
US20070089231A1 (en) * 2005-10-24 2007-04-26 Fendall, Inc. Emergency eyewash station having a peircing mechanism to puncture a sealed fluid bladder
WO2007106847A2 (en) * 2006-03-15 2007-09-20 Sperian Eye & Face Protection, Inc. Emergency eyewash station and dispensing structure therefor
DE112008001228T5 (de) 2007-05-04 2010-03-18 Abbott Medical Optics Inc., Santa Ana Verfahren und Vorrichtungen zum Messen von einem Tränenfilm und zum Diagnostizieren von Tränenfehlfunktionen
US7989404B2 (en) * 2008-02-11 2011-08-02 Clearwater International, Llc Compositions and methods for gas well treatment
GB2493568B (en) * 2011-08-09 2018-08-29 Zeiss Carl Meditec Ag Opthalmologic composition comprising an aqueous solution of at least one viscoelastic polysaccharide

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003991A (en) * 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
US4120792A (en) * 1977-08-15 1978-10-17 Thiokol Corporation Combined filter and incinerator
US4120949A (en) * 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4597965A (en) * 1979-06-06 1986-07-01 Holles Laboratories, Inc. Method and composition for controlling corneal hydration
US4412543A (en) * 1981-04-09 1983-11-01 Xanar, Inc. Apparatus for determining the concentration of a fluorescent material in an eye
US4883351A (en) * 1982-09-10 1989-11-28 Weiss Jeffrey N Apparatus for the detection of diabetes and other abnormalities affecting the lens of the eye
US5025785A (en) * 1982-09-10 1991-06-25 Weiss Jeffrey N Diabetes detection method
US4895159A (en) * 1982-09-10 1990-01-23 Weiss Jeffrey N Diabetes detection method
US4540568A (en) * 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
US4573778A (en) * 1983-03-16 1986-03-04 Boston University Aqueous fluorophotometer
US4594326A (en) * 1983-05-09 1986-06-10 Wade Stephen E Time-integrated measurement for determining substances in biological fluids
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4711540A (en) * 1984-01-04 1987-12-08 Tokyo Kogaku Kikai Kabushiki Kaisha Eye disease inspecting instrument
US4711541A (en) * 1984-02-02 1987-12-08 Tokyo Kogaku Kikai Kabushiki Kaisha Slit lamp and accessory device thereof
SE454842B (sv) * 1984-11-01 1988-06-06 Pharmacia Ab Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemne
US4702576A (en) * 1985-09-27 1987-10-27 Cambridge Instruments Inc. Ocular scattering analyzer
DE3542167A1 (de) * 1985-11-29 1987-06-04 Wolfgang Prof Dr Lohmann Verfahren zur messung der augen-linsen-truebung und anordnung zur durchfuehrung des verfahrens
CH671329A5 (de) * 1986-01-21 1989-08-31 Interzeag Ag
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4842401A (en) * 1987-06-15 1989-06-27 The Board Of Trustees Of The Leland Stanford Jr. University Eye diagnosis process
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same

Also Published As

Publication number Publication date
EP0603338B1 (de) 1997-03-05
US5323775A (en) 1994-06-28
ES2100362T3 (es) 1997-06-16
DE69217969T2 (de) 1997-06-12
EP0603338A1 (de) 1994-06-29
US5634458A (en) 1997-06-03
DE69217969D1 (de) 1997-04-10
AU2670892A (en) 1993-04-27
WO1993005699A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
ATE149310T1 (de) Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz
ATE76288T1 (de) Feste pharmaceutische zubereitung mit verlaengerter wirkstofffreigabe und verfahren zur herstellung.
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
ATE133336T1 (de) Verwendung von rapamycin zur herstellung eines arzneimittels zur behandlung von augenentzündungen
ATE61935T1 (de) Verfahren zur herstellung von mikrokapseln.
DE69105752T2 (de) Verfahren zur herstellung von florfenicol, seine analoga und oxazolinzwischenprodukte.
FR2422402A1 (fr) Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
LU77562A1 (de) Verfahren zur herstellung von neuen pharmazeutischen praeparaten
DE3785602D1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
ATA540478A (de) Verfahren zur herstellung von optisch aktiven alpha-hydroxycarbonsaeuren
AT363936B (de) Verfahren zur herstellung von neuen cyproheptadinderivaten und von deren pharmazeutisch verwendbaren salzen sowie optischen isomeren
DE69027221T2 (de) Substituierte 4-phenyl-4-piperidincarboxamide mit sowohl lokalanästhetischer als auch schmerzlindernder wirkung sowie verfahren zur herstellung
DE3764700D1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
SE8801710D0 (sv) New ophtalmological composition of matter
ATE131733T1 (de) Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese
DE3862017D1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
FR2390157A1 (fr) Produit et procede pour le traitement de l'ivoire dentaire par le cerium
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
KR880004810A (ko) 소화성 궤양 치료제
ATE49402T1 (de) Verfahren zur herstellung von zirkoniumcarboxylat.
DE3881484D1 (de) Optisch aktive produkte von 20,21-dinoreburnamenin-derivaten, verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
ATE2429T1 (de) 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties